Based in Findland and headed by Dr. Gino Cortopassi, Beiwe Health is developing medicines that extend longevity and kill cancer cells. Currently, they claim to have two drugs in phase one trials and one drug that has completed phase one trials. Gleioblastoma BEI-103 is not recorded on clinicaltrials.gov and little information is provided on its mechanism of action.
×
Beiwe Health – BEI-103
Receive our NewslEtter
Sign up to stay informed about the latest news and opportunities with LRI!
We respect your privacy. You can unsubscribe at any time.
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2025 Lifespan Research Institute – ALL RIGHTS RESERVED